Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Prelude Therapeutics Inc COMMON STOCK (PRLD).
- Disclosed ownership: 16%.
- Date of event: 21 Apr 2026.
ORBIMED ADVISORS LLC - 21 Apr 2026 SCHEDULE 13D/A Report for Prelude Therapeutics Inc COMMON STOCK (PRLD)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- PRLD
- Shares outstanding
- 80,844,194 shares
- Disclosed Ownership
- 12,935,071 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D/A
- Filing time
- 23 Apr 2026, 20:42:51 UTC
- Date of event
- 21 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 16% ownership in Prelude Therapeutics Inc COMMON STOCK (PRLD) on 21 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Apr 2026, 20:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 16% | 12,935,071 | 0 | 12,935,071 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| ORBIMED CAPITAL GP VI LLC | 15% | 11,808,945 | 0 | 11,808,945 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001682115 |
| OrbiMed Genesis GP LLC | 1.4% | 1,126,126 | 0 | 1,126,126 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001808744 |
| ORBIMED CAPITAL LLC | 1% | 789,500 | 789,500 | 0 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001157524 |